Safety of Off-Label Pharmacological Treatment in Pediatric Neuropsychiatric Disorders: A Global Perspective From an Observational Study at an Italian Third Level Children’s Hospital

Safety of Off-Label Pharmacological Treatment in Pediatric Neuropsychiatric Disorders: A Global Perspective From an Observational Study at an Italian Third Level Children’s Hospital

Background: The acquisition of proper and relevant pediatric clinical data is essential to ensure tolerable and effective pediatric drug therapies. In the field of pharmacological treatment of neuropsychiatric disorders, the lack of sufficient high quality scientific evidence for pediatric age resul...

Full description

Bibliographic Details
Main Authors: Maria Sole Giurin, Marta Paulina Trojniak, Anna Arbo, Marco Carrozzi, Giuseppe Abbracciavento, Lorenzo Monasta, Caterina Zanus
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Pharmacology
Subjects:
off-label
antipsychotics
antiepileptics
pediatric
pharmacovigilance
clinical pharmacist
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.837692/full

Similar Items

Similar Items